ELECTRONICALLY REPRINTED FROM MAY[removed]www.PharmExec.com Pharma[removed]

First Page		Document Content
Date: 2013-10-11 15:28:31 Pharmacy Health Pfizer Daiichi Sankyo Eisai Merck KGaA Purdue Pharma Schering AG Mylan Pharmaceutical sciences Pharmacology Pharmaceutical industry		ELECTRONICALLY REPRINTED FROM MAY[removed]www.PharmExec.com Pharma[removed] Add to Reading List Source URL: www.imsconsultinggroup.com Download Document from Source Website File Size: 2,18 MB Share Document on Facebook

	Mylan Agrees to Pay $465 Million in Restitution to Resolve False Claims Allegations The National Association of Medicaid Fraud Control units announced on August 17, 2017 that an agreement has been reached to settle alleg DocID: 1uUDJ - View Document
	Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills WILSON SONSINI GOODRICH & ROSATI DocID: 1trJa - View Document
	IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD MYLAN PHARMACEUTICALS INC., Petitioner v. SHIRE LABORATORIES, INC., DocID: 1tqnl - View Document
	Paper No. ____ Filed: November 22, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee () Michael T. Rosato () Jad A. Mills () DocID: 1tpON - View Document
	Paper No. ____ Filed: May 25, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills DocID: 1tkI9 - View Document